BioEnterprise

Venture Capital Investment In Midwest Life Sciences Balloons In First Half 2016

GRAND RAPIDS - Venture capital investments in Midwest health sciences companies ballooned during the first half of 2016, both in terms of deal flow and dollar value. Investors collectively put $1.04 billion into 218 deals involving Midwest-based health sciences companies between January and June, according to Cleveland-based BioEnterprise. That’s the largest amount and highest deal

By |2016-08-15T20:11:21-04:00August 15th, 2016|Life Sciences|

SBIR’s Unplugged Ohio Aerospace Institute Feb. 2

CLEVELAND - Hear from Industry leaders as they share their SBIR program experiences and best practices. Learn how they've successfully applied for SBIR contracts, get your questions answered, and network with other successful and aspiring companies. Participating companies include Apollo Medical Devices, iRxReminder, Thermalin Diabetes and SPR Therapeutics. BONUS: Attendees of this event will gain

By |2016-01-05T19:43:31-05:00January 5th, 2016|Life Sciences|